Careers  |  Sign In  |  Register

FDA Authorizes Use of Vaccine Not Yet Licensed in US

An article published by the Associated Press reports that after an outbreak of type B meningitis at Princeton University, the FDA has authorized the use of a vaccine produced by Novartis called Bexsero that is not yet licensed in the US. While New Jersey law requires all students to have a meningitis vaccine, the vaccine “does not prevent the B strain, which responds differently to vaccines from other strains.” Bexsero has been approved for use in other countries based on a study that safely vaccinated 8,000 people, and it is in the pipeline for approval in the US. Though the new vaccination is voluntary at Princeton beginning this week, already 2,000 students have received the vaccine.

Read the article published by the Associated Press.